A protein involved in ovarian cancer

Details for Australian Patent Application No. 2004285339 (hide)

Owner UCB Pharma S.A.

Inventors Burgess, Nicola Anne

Agent Watermark

Pub. Number AU-B-2004285339

PCT Pub. Number WO2005/042102

Priority 0324656.8 22.10.03 GB

Filing date 22 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 19 November 2009

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/042102 Priority application(s): WO2005/042102

14 February 2008 Assignment before Grant

  Celltech R&D Limited The application has been assigned to UCB Pharma S.A.

19 November 2009 Application Accepted

  Published as AU-B-2004285339

18 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285343-Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases

2004285337-Animal harness